Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff

ClinicalTrials.gov ID: NCT04497987

Public ClinicalTrials.gov record NCT04497987. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 2:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of LY3819253 Alone and in Combination With LY3832479 in Preventing SARS-CoV-2 Infection and COVID-19 in Skilled Nursing and Assisted Living Facility Residents and Staff; a NIAID and Lilly Collaborative Study

Study identification

NCT ID
NCT04497987
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,180 participants

Conditions and interventions

Interventions

  • Bamlanivimab Drug
  • Placebo Drug
  • Etesevimab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1, 2020
Primary completion
Jan 15, 2021
Completion
May 19, 2021
Last update posted
Feb 3, 2022

2020 – 2021

United States locations

U.S. sites
27
U.S. states
23
U.S. cities
26
Facility City State ZIP Site status
Unv of AL Sch of Med Div of Infectious Diseases Birmingham Alabama 35294
Care Access Research Phoenix Arizona 85023
Allergy and Asthma Clin of NW Ark Bentonville Arkansas 72712
Care Access Research LLC Huntington Beach California 92648
Alta Bates SMC Oakland California 94609
University of Colorado-Anschultz Medical Campus Aurora Colorado 80045
NIAID Miami Florida 33136
NIAID Decatur Georgia 30030
Belmont Village Lincoln Park Lincoln Park Illinois 60614
Family Medicine Indianapolis Indiana 46260
University of Louisville Louisville Kentucky 40202
Care Access Rch Lake Charles Lake Charles Louisiana 70601
Tulane University School of Medicine New Orleans Louisiana 70112 2715
NIAID - National Institute of Allergy & Infectious Diseases Bethesda Maryland 20892
Care Access Boston Massachusetts 02110
St. Paul IDA-CARe Saint Paul Minnesota 55101
Care Access Jackson Mississippi 39206
University of Mississippi Medical Center Jackson Mississippi 39216
Children's Hospital & Medical Center Omaha Nebraska 68114
Care Access Research - Bronx The Bronx New York 10456
NIAD Chapel Hill North Carolina 27599
Valley Medical Primary Care Centerville Ohio 45459
Univ of Cin College of Med Cincinnati Ohio 45219
OSU Med Intl Med Houston Ctr Tulsa Oklahoma 74127
Donahoe Manor Bedford Pennsylvania 15522
Belmont Village, West Univ Houston Texas 77025
Burke Internal Medicine and Research Burke Virginia 22015

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04497987, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2022 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04497987 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →